Unknown

Dataset Information

0

Brg1 loss attenuates aberrant wnt-signalling and prevents wnt-dependent tumourigenesis in the murine small intestine.


ABSTRACT: Tumourigenesis within the intestine is potently driven by deregulation of the Wnt pathway, a process epigenetically regulated by the chromatin remodelling factor Brg1. We aimed to investigate this interdependency in an in vivo setting and assess the viability of Brg1 as a potential therapeutic target. Using a range of transgenic approaches, we deleted Brg1 in the context of Wnt-activated murine small intestinal epithelium. Pan-epithelial loss of Brg1 using VillinCreERT2 and AhCreERT transgenes attenuated expression of Wnt target genes, including a subset of stem cell-specific genes and suppressed Wnt-driven tumourigenesis improving animal survival. A similar increase in survival was observed when Wnt activation and Brg1 loss were restricted to the Lgr5 expressing intestinal stem cell population. We propose a mechanism whereby Brg1 function is required for aberrant Wnt signalling and ultimately for the maintenance of the tumour initiating cell compartment, such that loss of Brg1 in an Apc-deficient context suppresses adenoma formation. Our results highlight potential therapeutic value of targeting Brg1 and serve as a proof of concept that targeting the cells of origin of cancer may be of therapeutic relevance.

SUBMITTER: Holik AZ 

PROVIDER: S-EPMC4091792 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Brg1 loss attenuates aberrant wnt-signalling and prevents wnt-dependent tumourigenesis in the murine small intestine.

Holik Aliaksei Z AZ   Young Madeleine M   Krzystyniak Joanna J   Williams Geraint T GT   Metzger Daniel D   Metzger Daniel D   Shorning Boris Y BY   Clarke Alan R AR  

PLoS genetics 20140710 7


Tumourigenesis within the intestine is potently driven by deregulation of the Wnt pathway, a process epigenetically regulated by the chromatin remodelling factor Brg1. We aimed to investigate this interdependency in an in vivo setting and assess the viability of Brg1 as a potential therapeutic target. Using a range of transgenic approaches, we deleted Brg1 in the context of Wnt-activated murine small intestinal epithelium. Pan-epithelial loss of Brg1 using VillinCreERT2 and AhCreERT transgenes a  ...[more]

Similar Datasets

| S-EPMC4333197 | biostudies-literature
| S-EPMC8058071 | biostudies-literature
| S-EPMC7873381 | biostudies-literature
2013-08-07 | E-GEOD-46129 | biostudies-arrayexpress
2019-12-31 | GSE124662 | GEO
| S-EPMC6374445 | biostudies-literature
| S-EPMC5793173 | biostudies-literature
2013-08-07 | GSE46129 | GEO
2021-03-11 | GSE167876 | GEO
| 2416626 | ecrin-mdr-crc